Verona Pharma Ltd - Company Profile
Powered by 
All the sales intelligence you need on Verona Pharma Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Verona Pharma Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Verona Pharma Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Verona Pharma Ltd (Verona Pharma), a subsidiary of Merck & Co Inc, is a biopharmaceutical company focused on developing therapeutics for chronic respiratory conditions. Its major strengths include intellectual property and its lead product candidate, Ensifentrine. However, the company's history of operating losses could be a significant concern. Verona Pharma stands to benefit from the market potential in cystic fibrosis, the regulatory approval of Ohtuvayre, and its agreement with Oaktree and OMERS. Nonetheless, rapid technological changes, stiff competition, and stringent regulations could pose challenges to the company’s future business prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer